Phyton Biotech Partners with Agenus to Revolutionize QS-21 Production
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient
Phyton Biotech will be attending the 37th Annual J.P. Morgan Health Care Conference from January 7 to 10, 2019 in San Francisco.
Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager.
Phyton Biotech recently attended BIO-Europe 2018: the 24th Annual International Partnering Conference in Copenhagen, Denmark.
Phyton Biotech will be at BIOEurope in beautiful Copenhagen from November 5-7. Visit us at the Life Science Nord booth #97 and learn how our unique Plant Cell Fermentation (PCF®) platform can support your company's needs for plant-derived active ingredients.
Phyton Biotech recently attended CPhI Worldwide in Madrid, Spain, where we showcased our award-winning and environmentally responsible Plant Cell Fermentation (PCF ®) technology for the production of Paclitaxel and Docetaxel and other high-value phytochemicals.
As global leaders in plant cell fermentation, Phyton Biotech is pleased to announce our participation at CPhI Worldwide in Madrid, Spain from October 9-11, 2018.